Novo Nordisk Global Business Services (GBS) and Manipal Academy for Higher Education (MAHE) have inked a Memorandum of Understanding (MoU) to explore opportunities to collaborate across the pharma value chain and its application in the healthcare ecosystem.

Under the terms of the MoU, MAHE, and Novo Nordisk GBS will jointly engage in initiatives including, innovation projects, hackathons, case competitions, guest lectures, education programs, internships, placements, employee development, and corporate social responsibility collaborations. The MoU was signed on August 3 at the Manipal campus and will be effective for a period of two years.

Dr Sharath Rao, Pro Vice Chancellor – Health Sciences, MAHE said “MAHE and Novo Nordisk GBS will work together to develop training programmes and workshops to enhance the skills of healthcare professionals, researchers, and students. This collaboration will promote continuous learning, foster interdisciplinary collaboration, and empower individuals to excel in their respective fields.”  

Dr C Mallikarjuna Rao, Principal of Manipal College of Pharmaceutical Sciences said that he would be delighted to initiate a centre on Pharmacoepidemiology and Pharmacoeconomics. The proposed centre will offer certificate programs and research collaboration with Novo Nordisk. 

This will be the second partnership for Novo Nordisk GBS with the academia, having signed an MoU with IIIT Bangalore in May 2023. Besides fostering knowledge sharing between industry and academia, the partnership will also provide students at MAHE with opportunities to gain real-world experiences, develop new skills, and build relationships with leading industry professionals.